Neurocrine to buy Soleno Therapeutics for $53/share in cash.
Share this article
Corporate
Score 65
Neutral
Neurocrine to buy Soleno Therapeutics for $53/share in cash
Apr 06, 2026 11:10 UTC
NBIX, SLNO, ^GSPC
Short term
Related Articles
Score 55
Bearish
Apple’s foldable iPhone encounters engineering snags, faces potential shipment delays, Nikkei Asia reports
Apr 07, 03:00
Score 85
Bullish
SpaceX plans outsized retail allocation in record IPO, Reuters reports
Apr 07, 02:44
Score 25
Edwards Lifesciences CVP Lippis sells $82,522 in stock
Apr 07, 00:47
Score 25
Form 144 Alignment Healthcare For: 6 April
Apr 07, 00:33
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.